First Human Data: Hyperpolarized Pyruvate Injection in Subjects with Prostate Cancer (IMAGE)

University of California - San Francisco

First Human Data: Hyperpolarized Pyruvate Injection in Subjects with Prostate Cancer

Caption

A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor's metabolism.

Credit

UCSF

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.